Skip to main content
SpringerLink
Log in

Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019)

Diagnosis, treatment and monitoring of diabetic eye disease (Update 2019)

  • leitlinien für die praxis
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Diabetes mellitus kann diabetische Retinopathie, diabetisches Makulaödem, Optikusneuropathie, Katarakt, Sekundärglaukom und Fehlfunktionen der äußeren Augenmuskeln verursachen. Die Inzidenz dieser Spätschäden korreliert mit der Dauer des Diabetes und mit dem Grad der metabolischen Kontrolle. Die Empfehlungen der Österreichischen Diabetes Gesellschaft für Diagnose, Therapie und Nachkontrolle werden übersichtsweise und bezogen auf die jeweiligen Stadien der diabetischen Augenerkrankung präsentiert.

Summary

Diabetes mellitus can cause diabetic retinopathy, diabetic macular edema, optic neuropathy, cataract or dysfunction of the eye muscles. The incidence of these defects correlates with disease duration and quality of metabolic control. Recommendations of the Austrian Diabetes Association for diagnosis, therapeutic procedures and requirements for adequate follow-up depending on stage of diabetic eye disease are summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Khadem J, Buzney S, Alich K. Practice patterns in diabetic retinopathy: part 1: analysis of retinopathy follow-up. Arch Ophthalmol. 1999;117(6):815–20.

    Article  CAS  PubMed  Google Scholar 

  2. McCarty C, Taylor K, McKay R, et al. Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists. Clin Exp Ophthalmol. 2001;29(2):52–8.

    Article  CAS  PubMed  Google Scholar 

  3. Wilkinson C, Ferris F, Klein R, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.

    Article  CAS  PubMed  Google Scholar 

  4. Hazin R, Colyer M, Lum F, et al. Revisiting diabetes 2000: challenges in establishing nationwide diabetic retinopathy prevention programs. Am J Ophthalmol. 2011;152(5):723–9.

    Article  PubMed  Google Scholar 

  5. Hammes H, Lemmen K. Diagnostik, Therapie und Verlaufskontrolle der diabetischen Retinopathie und Makulopathie. Diabetes Stoffwechs. 2002;11(Suppl 2):15–6.

    Google Scholar 

  6. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15(12):1875–91.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang L, Krzentowski G, Albert A, et al. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24(7):1275–9.

    Article  CAS  PubMed  Google Scholar 

  8. Stratton I, Kohner E, Aldington S, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 yrs from diagnosis. Diabetologia. 2001;44(2):156–63.

    Article  CAS  PubMed  Google Scholar 

  9. Murphy RP, Nanda M, Plotnick L, et al. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol. 1990;108(2):215–8.

    Article  CAS  PubMed  Google Scholar 

  10. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care. 2000;23(8):1084–91.

    Article  PubMed Central  Google Scholar 

  11. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116(7):874–86.

    Article  Google Scholar 

  12. Orchard T, Forrest K, Kuller L, et al. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2001;24(6):1053–9.

    Article  CAS  PubMed  Google Scholar 

  13. Sen K, Misra A, Kumar A, et al. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract. 2002;56(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  14. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–13.

    Article  PubMed Central  Google Scholar 

  15. Nasr C, Hoogwerf B, Faiman C, et al. United Kingdom Prospective Diabetes Study (UKPDS). Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus. Cleve Clin J Med. 1999;66(4):247–53.

    Article  CAS  PubMed  Google Scholar 

  16. Davis M, Fisher M, Gangnon R, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study report number 18. Invest Ophthalmol Vis Sci. 1998;39(2):233–52.

    CAS  PubMed  Google Scholar 

  17. Kinyoun J, Barton F, Fisher M, et al. Detection of diabetic macular edema. Ophthalmoscopy versus photography—Early Treatment Diabetic Retinopathy Study report number 5. The ETDRS Research Group. Ophthalmology. 1989;96(6):746–50.

    Article  CAS  PubMed  Google Scholar 

  18. Gonzalez Villalpando C, Gonzalez Villalpando ME, Martinez Diaz S, et al. A diabetic retinopathy screening program as a strategy for blindness prevention. Arch Med Res. 1997;28(1):129–35.

    CAS  PubMed  Google Scholar 

  19. Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914–20.

    Article  PubMed  Google Scholar 

  20. Baskin DE. Optical coherence tomography in diabetic macular edema. Curr Opin Ophthalmol. 2010;21(3):172–7.

    Article  PubMed  Google Scholar 

  21. Tangelder GJ, Van der Heijde RG, Polak BC, et al. Precision and reliability of retinal thickness measurements in foveal and extrafoveal areas of healthy and diabetic eyes. Invest Ophthalmol Vis Sci. 2008;49(6):2627–34.

    Article  PubMed  Google Scholar 

  22. Browning DJ, Fraser CM. The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. Am J Ophthalmol. 2008;145(1):149–54.

    Article  PubMed  Google Scholar 

  23. Bolz M, Ritter M, Schneider M, et al. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema. Ophthalmology. 2009;116(1):66–72.

    Article  PubMed  Google Scholar 

  24. Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Ophthalmology. 1991;98(Suppl 5):834–40.

    Google Scholar 

  25. Pandit RJ, Taylor R. Quality assurance in screening for sight-threatening diabetic retinopathy. Diabet Med. 2002;19(4):285–91.

    Article  CAS  PubMed  Google Scholar 

  26. Kuo HK, Hsieh HH, Liu RT. Screening for diabetic retinopathy by one-field, non-mydriatic, 45 degrees digital photography is inadequate. Ophthalmologica. 2005;219(5):292–6.

    Article  PubMed  Google Scholar 

  27. The Early Treatment Diabetic Retinopathy Study Research Group. Case reports to accompany Early Treatment Diabetic Retinopathy Study reports 3 and 4. Int Ophthalmol Clin. 1987;27(4):273–333.

    Article  Google Scholar 

  28. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;5(1):823–33.

    Google Scholar 

  29. Lindgren G, Lindblom B. Causes of vitreous hemorrhage. Curr Opin Ophthalmol. 1996;7(3):13–9.

    Article  CAS  PubMed  Google Scholar 

  30. Fong D, Ferris F, Davis M, et al. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;127(2):137–41.

    Article  CAS  PubMed  Google Scholar 

  31. Antcliff R, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999;14(4):223–32.

    Article  CAS  PubMed  Google Scholar 

  32. The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287(19):2542–51.

    Article  Google Scholar 

  33. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology. 1987;94(7):761–74.

    Article  Google Scholar 

  34. Kohner E, Stratton I, Aldington S, et al. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med. 2001;18(3):178–84.

    Article  CAS  PubMed  Google Scholar 

  35. The Diabetes Control and Complications Trial. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 1995;113(1):36–51.

    Article  Google Scholar 

  36. Squirrell D, Bhola R, Bush J, et al. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol. 2002;86(5):565–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Flesner P, Sander B, Henning V, et al. Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications. Acta Ophthalmol Scand. 2002;80(1):19–24.

    Article  PubMed  Google Scholar 

  38. Chung J, Kim MY, Kim HS, et al. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg. 2002;28(4):626–30.

    Article  PubMed  Google Scholar 

  39. Cunha-Vaz J. Lowering the risk of visual impairment and blindness. Diabet Med. 1998;15(Suppl 4):S47–S50.

    Article  PubMed  Google Scholar 

  40. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–13.

    Article  PubMed Central  Google Scholar 

  41. Aiello LP, Beck RW, Bressler NM, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118(12):e5–e14.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064–77.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010;117(11):2146–51.

    Article  PubMed  Google Scholar 

  44. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010;33(11):2399–405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Elman MJ, Bressler NM, Qin H, et al. Expanded 2‑year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4):609–14.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801.

    Article  PubMed  Google Scholar 

  47. Elman MJ, et al. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5‑year randomized trial results. Ophthalmology. 2015;122(2):375–81. https://doi.org/10.1016/j.ophtha.2014.08.047.

    Article  PubMed  Google Scholar 

  48. Korobelnik JF, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–54. https://doi.org/10.1016/j.ophtha.2014.05.006.

    Article  PubMed  Google Scholar 

  49. The Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–203. https://doi.org/10.1056/NEJMoa1414264.

    Article  CAS  PubMed Central  Google Scholar 

  50. Elman MJ, Bressler NM, Qin H, et al. Expanded 2‑year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4):609–14.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25.

    Article  PubMed  Google Scholar 

  52. Elman MJ, et al. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5‑year randomized trial results. Ophthalmology. 2015;122(2):375–81. https://doi.org/10.1016/j.ophtha.2014.08.047.

    Article  PubMed  Google Scholar 

  53. Boyer DS. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904–14. https://doi.org/10.1016/j.ophtha.2014.04.024.

    Article  PubMed  Google Scholar 

  54. Campochiaro PA. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011;118(4):626–635.e2. https://doi.org/10.1016/j.ophtha.2010.12.028.

    Article  PubMed  Google Scholar 

  55. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383–96.

    Article  Google Scholar 

  56. The Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study report no. 3. Int Ophthalmol Clin. 1987;27(4):254–64.

    Article  Google Scholar 

  57. Googe J, Brucker AJ, Bressler NM, et al. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina. 2011;31(6):1009–27.

    Article  CAS  PubMed  Google Scholar 

  58. Ferris F. Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc. 1996;94:505–37.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Bodanowitz S, Hesse L, Weinand F, et al. Vitrectomy in diabetic patients with a blind fellow eye. Acta Ophthalmol Scand. 1996;74(1):84–8.

    Article  CAS  PubMed  Google Scholar 

  60. Filho JA, Messias A, Almeida FP, et al. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Acta Ophthalmol. 2011;89(7):567–72.

    Article  CAS  Google Scholar 

  61. Kohner EM, Barry PJ. Prevention of blindness in diabetic retinopathy. Diabetologia. 1984;26(3):173–9.

    Article  CAS  PubMed  Google Scholar 

  62. Rand LI, Prud’homme GJ, Ederer F, et al. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) report no. 10. Invest Ophthalmol Vis Sci. 1985;26(7):983–91.

    CAS  PubMed  Google Scholar 

  63. Dogru M, Nakamura M, Inoue M, et al. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation. Jpn J Ophthalmol. 1999;43(3):217–24.

    Article  CAS  PubMed  Google Scholar 

  64. Stanga PE, Papayannis A, Tsamis E, et al. New findings in diabetic maculopathy and proliferative disease by swept-source optical coherence tomography angiography. Dev Ophthalmol. 2016;56:113–21.

    Article  PubMed  Google Scholar 

  65. De Barros Garcia J, Isaac DLC, Avila M. Diabetic retinopathy and OCT angiography: clinical findings and future perspectives. Int J Retina Vitreous. 2017;3:14.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Cao D, Yang D, Huang Z, et al. Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy. Acta Diabetol. 2018;55(5):469–77.

    Article  PubMed  Google Scholar 

  67. Schreur V, Domanian A, Liefers B, et al. Morphological and topographical appearance of microaneurysms on optical coherence tomography angiography. Br J Ophthalmol. 2018;.

  68. Gross JG, Glassman AR, et al. A novel treatment for proliferative diabetic retinopathy: anti-vascular endothelial growth factor therapy. JAMA Ophthalmol. 2016;134(1):13–4. https://doi.org/10.1001/jamaophthalmol.2015.5079.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Augenheilkunde, Hanusch-Krankenhaus, Heinrich-Collin-Straße 30, 1140, Wien, Österreich

    Stephan Radda

  2. Universitätsklinik für Augenheilkunde und Optometrie, Kepler Universitätsklinikum, Linz, Österreich

    Matthias Bolz

  3. Universitätsklinik für Augenheilkunde und Optometrie, Uniklinikum, Paracelsus Medizinische Privatuniversität, Salzburg, Österreich

    Stefan Egger

  4. Universitäts-Augenklinik, Medizinische Universität Graz, Graz, Österreich

    Vanessa Gasser-Steiner & Andreas Wedrich

  5. Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck, Innsbruck, Österreich

    Martina Kralinger

  6. Abteilung für Augenheilkunde, Landeskrankenhaus Feldkirch, Feldkirch, Österreich

    Stefan Mennel

  7. Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Wien, Wien, Österreich

    Christoph Scholda

  8. Augenabteilung, Krankenanstalt Rudolfstiftung und SMZ Ost – Donauspital, Wien, Österreich

    Ulrike Stolba

Authors
  1. Stephan Radda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Bolz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Egger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vanessa Gasser-Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martina Kralinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stefan Mennel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christoph Scholda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ulrike Stolba
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andreas Wedrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

die Netzhautkommission der Österreichischen Ophthalmologischen Gesellschaft

Corresponding author

Correspondence to Stephan Radda.

Ethics declarations

Interessenkonflikt

S. Radda, M. Bolz, S. Egger, V. Gasser-Steiner, M. Kralinger, S. Mennel, C. Scholda, U. Stolba und A. Wedrich geben an, dass kein Interessenkonflikt besteht.

Additional information

Prim. PD Dr. Katharina Krepler ist Vorsitzende der Netzhautkommission der Österreichischen Ophthalmologischen Gesellschaft

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Radda, S., Bolz, M., Egger, S. et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019). Wien Klin Wochenschr 131 (Suppl 1), 164–168 (2019). https://doi.org/10.1007/s00508-019-1445-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-019-1445-1

Schlüsselwörter

Keywords

Search

Navigation